Table 2. Distribution of tumor markers in different stages of NSCLC and SCLC.
Variable | Median | Cut-off | |
---|---|---|---|
NSCLC | SCLC | ||
ProGRP (ng/L) | |||
I | 35.5 | 168.6 | 56.0 |
II | 35.3 | 312.7 | 61.0 |
I–II | 35.0 | 253.3 | 56.0 |
III | 35.0 | 618.1 | 71.0 |
IV | 34.5 | 1,365.8 | 99.0 |
NSE (µg/L) | |||
I | 11.7 | 14.2 | 13.0 |
II | 13.0 | 18.1 | 17.0 |
III | 13.5 | 29.1 | 22.0 |
IV | 14.8 | 53.6 | 26.0 |
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; ProGRP, roles of gastrin-releasing peptide; NSE, neuron-specific enolase.